ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TKNO Alpha Teknova Inc

1.80
-0.01 (-0.55%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Alpha Teknova Inc NASDAQ:TKNO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.01 -0.55% 1.80 1.56 2.07 1.98 1.81 1.82 2,876 21:30:00

Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

21/02/2024 9:01pm

GlobeNewswire Inc.


Alpha Teknova (NASDAQ:TKNO)
Historical Stock Chart


From Feb 2024 to May 2024

Click Here for more Alpha Teknova Charts.

Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2023, on Monday, March 11, 2024, following the close of market.

Teknova will host a webcast and conference call on Monday, March 11, 2024, beginning at 5:30 p.m. Eastern Time. Participants can access the live webcast on the Investor Relations section of the Teknova website and at this link: https://edge.media-server.com/mmc/p/qqayy3wz. To receive a PIN number for dial in, participants can register for the webcast via this link: https://register.vevent.com/register/BI6c01344c805a4906b6dc3b443dd64af3. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Teknova   Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel therapies that will help people live longer, healthier lives. Teknova offers fully customizable solutions for every stage of the workflow, supporting industry leaders in cell and gene therapy, molecular diagnostics, and synthetic biology. The Company’s fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps their customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 200,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by its team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of novel therapies. 

Investor Contacts Matt Lowell Chief Financial Officer matt.lowell@teknova.com+1 831-637-1100

Media Contact Jennifer Henry  Senior Vice President, Marketing jenn.henry@teknova.com  +1 831-313-1259

1 Year Alpha Teknova Chart

1 Year Alpha Teknova Chart

1 Month Alpha Teknova Chart

1 Month Alpha Teknova Chart

Your Recent History

Delayed Upgrade Clock